281 related articles for article (PubMed ID: 31568657)
1. lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.
Zeng XY; Jiang XY; Yong JH; Xie H; Yuan J; Zeng D; Dou YY; Xiao SS
Cancer Med; 2019 Nov; 8(16):7074-7085. PubMed ID: 31568657
[TBL] [Abstract][Full Text] [Related]
2. Role of the lncRNA ABHD11-AS
Wu DD; Chen X; Sun KX; Wang LL; Chen S; Zhao Y
Mol Cancer; 2017 Aug; 16(1):138. PubMed ID: 28818073
[TBL] [Abstract][Full Text] [Related]
3. EZH2-mediated lncRNA ABHD11-AS1 promoter regulates the progression of ovarian cancer by targeting miR-133a-3p.
Zhang W; Huang X; Shi J
Anticancer Drugs; 2021 Mar; 32(3):269-277. PubMed ID: 33491971
[TBL] [Abstract][Full Text] [Related]
4. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
6. LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway.
Lu H; Zhu C; Chen Y; Ruan Y; Fan L; Chen Q; Wei Q
Clin Transl Oncol; 2022 Jun; 24(6):1124-1133. PubMed ID: 35098448
[TBL] [Abstract][Full Text] [Related]
7. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
8. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
Zhao J; Liu HR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3.
Jia J; Li F; Tang XS; Xu S; Gao Y; Shi Q; Guo W; Wang X; He D; Guo P
Oncotarget; 2016 Jun; 7(25):37868-37881. PubMed ID: 27191265
[TBL] [Abstract][Full Text] [Related]
10. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression.
Wu W; Gao H; Li X; Zhu Y; Peng S; Yu J; Zhan G; Wang J; Liu N; Guo X
Cancer Sci; 2019 May; 110(5):1587-1598. PubMed ID: 30941821
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
12. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
[TBL] [Abstract][Full Text] [Related]
14. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.
Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z
Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
16. CREB1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis.
Tong L; Wang Y; Ao Y; Sun X
Biomed Pharmacother; 2019 Jul; 115():108891. PubMed ID: 31082772
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
Zhao X; Cheng Z; Wang J
Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
[TBL] [Abstract][Full Text] [Related]
18. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
Ma SY; Wei P; Qu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4.
Huang K; Chen X; Geng Z; Xiong X; Cong Y; Pan X; Liu S; Ge L; Xu J; Jia X
Funct Integr Genomics; 2023 Mar; 23(2):110. PubMed ID: 36995496
[TBL] [Abstract][Full Text] [Related]
20. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
